Clinical Trial Update: Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating a cancer vaccine therapy in combination with Basiliximab for adults with acute myeloid leukemia (in remission and several chromo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Myeloid Leukemia with
• Acute Myeloid Leukemia with 11q23 Abnormalities
• Acute Myeloid Leukemia with Del
• Acute Myeloid Leukemia with Inv

Drugs mentioned

• Simulect (Basiliximab)
• vaccine therapy (unspecified)

Snippet

Sponsor: University of Chicago | Conditions: Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Phase 1 | Status: COMPLETED